ArticleReproductive sciences (Thousand Oaks, Calif.)2026
Estrogen-Induced Nesfatin-1 Expression Modulates Endometrial Decidualization in Mice.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nesfatin-1 across human reproduction and early life: implications for infertility, pregnancy complications, and lactation.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nesfatin-1 is a peptide hormone that is commonly associated with appetite regulation and is primarily expressed in the brain. However, it has recently been identified in various peripheral organs, including the ovaries and uterus. This study aimed to investigate the expression and functional role of nesfatin-1 in the mouse endometrium. Due to the lack of established mouse endometrial cell lines, a primary culture system was developed by isolating endometrial cells through enzymatic digestion, enabling in vitro analyses. We examined the presence and regulatory potential of nesfatin-1 in these cells, focusing particularly on endometrial decidualization, a critical process for implantation and pregnancy maintenance. Our results revealed that nesfatin-1 and its binding sites are expressed in mouse endometrial cells. Furthermore, Nucb2 mRNA expression was significantly increased following estradiol treatment but not progesterone treatment, suggesting hormone-specific regulation of nesfatin-1 expression. Notably, nesfatin-1 treatment to mouse endometrial cells resulted in a significant upregulation of decidualization-associated genes, including prolactin family 8, subfamily a, member 2 (Prl8a2), alkaline phosphatase (Alpl), and bone morphogenetic protein 2 (Bmp2). Furthermore, in a delayed implantation mice model, there was a significant decrease in Nucb2/nesfatin-1 expression and decidualization-associated genes. Importantly, nesfatin-1 administration restored the expression of these genes in the delayed implantation conditions. Taken together, these findings demonstrate that nesfatin-1 plays a pivotal role in promoting endometrial decidualization and successful implantation, suggesting its potential as a therapeutic target for enhancing fertility and improving pregnancy outcomes.
Indexed as
Identifiers
41402611What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.